Diane Carman
General Counsel at WINDTREE THERAPEUTICS, INC.
Net worth: 243 $ as of 2024-05-30
Network origin in Diane Carman first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 14 | |
12
| Subsidiary | Biotechnology | 12 |
| Public Company | Medical Specialties | 2 | |
Vitara Biomedical, Inc.
 Vitara Biomedical, Inc. Packaged SoftwareTechnology Services Vitara Biomedical, Inc. engages in the biotechnology business. The company is headquartered in Philadelphia, PA.
1
| Holding Company | Packaged Software | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Diane Carman via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
| OCULAR THERAPEUTIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
2941881 Canada, Inc.
 2941881 Canada, Inc. Medical SpecialtiesHealth Technology 2941881 Canada, Inc. manufactures and supplies pelvic health and gastrointestinal equipment and consumables. The company was founded by Raymond George Yves Laborie in 1967 and is headquartered in Mississauga, Canada. | Medical Specialties | Chairman | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman | |
| MORPHOSYS AG | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Ionix Pharmaceuticals Ltd.
 Ionix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ionix Pharmaceuticals Ltd. used to develop analgesic medicines for the treatment of acute and chronic pain. Its drugs were used for the treatment of pain associated with chronic debilitating diseases such as osteoarthritis, diabetes, cancer and multiple sclerosis. The company was founded by Andrew Sandham, Phillip J. Birch, John Wood and Ann Gail Hayes in 2001 and was located in Cambridge, UK. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor | |
| The University of Texas at Austin | College/University | Doctorate Degree Doctorate Degree | |
| University of Iowa | College/University | Undergraduate Degree | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director of Finance/CFO General Counsel | |
| The University of Sheffield | College/University | Doctorate Degree Undergraduate Degree | |
| University of Utrecht | College/University | Graduate Degree Undergraduate Degree | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
INO Therapeutics LLC
 INO Therapeutics LLC Pharmaceuticals: MajorHealth Technology INO Therapeutics LLC engages in the development of pharmaceutical drugs. The company is headquartered in Hampton, NJ. | Pharmaceuticals: Major | Sales & Marketing | |
CDI Bioscience, Inc.
 CDI Bioscience, Inc. BiotechnologyHealth Technology CDI Bioscience, Inc. has developed an innovative technology for increased yield of bioproducts, manufactured in cellular systems. Genetic engineering technology is used to control the metabolism of cells, thus shifting the cell from explicative to production mode (RP Shift®). In particular, this technology has been designed for use in mammalian cells, unlocking their potential to produce proteins, peptides and enzymes. The current design of the technology can be readily translated to bacterial and yeast cellular systems for the production of commercial grade bio products. Recombinant therapeutic proteins have proven to be invaluable biopharmaceuticals for the treatment of chronic and life-threatening diseases. While exceptionally effective, the dosage requirements are generally very high for the required treatment. Several hundred milligrams of protein per administration is common and multiple doses are often required and being protein based drugs, they can only be produced by living cells which is why increasing production yield is a challenge. CDI Bioscience has developed a patented technology that dramatically improves the product yield in biopharmaceutical manufacturing. CDI's core technology, RP Shift®, solves a number of intermediate problems in the development of biopharmaceutical products by significantly boosting the productivity and viability of production cells. | Biotechnology | Director/Board Member | |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor | |
| TREVENA, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| Yamanouchi Nordic | Corporate Officer/Principal | ||
| Synthélabo Scandinavia A/S | Corporate Officer/Principal | ||
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Inomax LLC (Florida)
 Inomax LLC (Florida) Investment ManagersFinance Inomax LLC is an American venture capital company. | Investment Managers | Corporate Officer/Principal | |
Datex-Ohmeda, Inc.
 Datex-Ohmeda, Inc. Industrial ConglomeratesProducer Manufacturing Part of General Electric Co., Datex-Ohmeda, Inc. develops and manufactures medical equipment. The company is based in Madison, WI. | Industrial Conglomerates | Corporate Officer/Principal | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Pfizer ApS
 Pfizer ApS Medical DistributorsDistribution Services Part of Pfizer Inc., Pfizer ApS is a Danish bio-pharmaceutical company. The company is based in Ballerup, Denmark. Pfizer is one of the world's leading bio-pharmaceutical companies. | Medical Distributors | Corporate Officer/Principal | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Olin Business School | College/University | Masters Business Admin | |
| University of Antwerp | College/University | Graduate Degree Graduate Degree | |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Medical Specialties | Founder | |
The Capital Network, Inc.
 The Capital Network, Inc. Miscellaneous Commercial ServicesCommercial Services The Capital Network, Inc. is a private company based in Wellesley, MA that provides founder-focused fundraising education programs. The company aims to create a more inclusive and accessible funding ecosystem to support female and other first-time founders of early stage startups. The company offers three programs: the Fellowship for Female Founders, Fundraising Readiness Workshops, and the Investment and Inclusion Series. The Fellowship for Female Founders is a six-month program that has helped over 90+ female founders raise over $85m in capital. The company also offers ongoing workshops for first-time startup founders and a series of honest conversations to bring about meaningful systemic change. The Capital Network has a network of 300+ investors and sponsors who help them make the fundraising ecosystem work for everybody. The company was founded by Ashkan Afkhami and Chula Reynolds. | Miscellaneous Commercial Services | Director/Board Member | |
| BIOTALYS NV | Chemicals: Agricultural | Director of Finance/CFO Director/Board Member | |
| PROQR THERAPEUTICS N.V. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOCARTIS GROUP NV | Medical Specialties | Chief Executive Officer Chief Operating Officer | |
| UI College of Pharmacy | College/University | Director/Board Member | |
| ASCELIA PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
| Innoventa Medica ApS | Chairman | ||
Amylon Therapeutics BV
 Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chairman Chief Executive Officer | |
| Janssen Biotherapeutics | Corporate Officer/Principal Corporate Officer/Principal | ||
| SEQUANA MEDICAL N.V. | Medical Specialties | Director/Board Member Investor Relations Contact | |
| CMC Sweden AB | Director/Board Member | ||
| Life Science Cares, Inc. | Director/Board Member | ||
Hc Bioscience, Inc.
 Hc Bioscience, Inc. Pharmaceuticals: MajorHealth Technology hC Bioscience, Inc. is a biotech company based in Cambridge, MA and has subsidiaries in the United States. A single trna therapy has the potential to treat many diseases, regardless of the gene or location of the mutation. hC Bioscience is dedicated to improving the lives of patients by developing first-in-class trna-based therapeutics that target protein dysfunction. The company's innovative approach to precision protein editing has the potential to treat genetically defined conditions that account for 10-15% of all human diseases. The lead platform in development is directed at restoring protein function in diseases caused by nonsense mutations or premature termination codons (PTCs). The company was founded in 2021 by Leslie J. Williams, who has been the CEO since then. | Pharmaceuticals: Major | Founder |
Statistics
International
| United States | 25 |
| Belgium | 7 |
| Denmark | 7 |
| Germany | 4 |
| Sweden | 4 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 9 |
| Finance | 5 |
| Producer Manufacturing | 2 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 155 |
| Corporate Officer/Principal | 74 |
| Chairman | 60 |
| Independent Dir/Board Member | 49 |
| Chief Executive Officer | 26 |
Most connected contacts
| Insiders | |
|---|---|
| Zuie Chin Huang | 40 |
| Edwin Moses | 35 |
| Bo Jesper Hansen | 34 |
| Catherine Moukheibir | 29 |
| Peter John Fellner | 21 |
| Mark Strobeck | 21 |
| Leslie Williams | 19 |
| Huai Zheng Peng | 19 |
| Hilde Windels | 18 |
| Robert Scott | 15 |
| Evan Loh | 14 |
| John Hamill | 13 |
| Bernard E. Lyons | 12 |
| Antonin Rollet de Fougerolles | 9 |
| Robert Friesen | 9 |
- Stock Market
- Insiders
- Diane Carman
- Company connections
